Sustratos genéticos de la psicosis asociada al cannabis
Revista Española de Drogodependencias December 30, 2022 DOI: 10.54108/10029 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Cannabis |
| Key findings | The article argues that cannabis-associated psychosis is a distinct nosological entity separate from idiopathic schizophrenia and other psychotic disorders. |
Abstract
Este artículo resumirá los principales sustratos de las psicosis asociadas al cannabis. En primer lugar, se introducirá un marco epistemológico para apoyar la existencia de una “psicosis asociada al cannabis” específica como entidad nosológica distinta de la esquizofrenia idiopática y otros trastornos psicóticos. A continuación, se examinarán las principales características clínicas de las psicosis asociadas al cannabis. Por último, se presentarán los correlatos biológicos y genéticos de las psicosis asociadas al cannabis.
Comparable studies
Other narrative reviews on cannabis, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Causal association between cannabis and psychosis: examination of the evidence | 2004 | Review | |
| Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history. General (historical and pharmacological review) | 2018 | Review | |
| Psychiatric effects of cannabis | 2001 | Review | |
| Beyond THC: The New Generation of Cannabinoid Designer Drugs | 2011 | Review | |
| Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug | 2006 | Review |
Citations in the library
Cites 16
- Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment Journal of Psychopharmacology October 5, 2012
- Traditional marijuana, high‐potency cannabis and synthetic cannabinoids: increasing risk for psychosis World Psychiatry September 22, 2016
- “Spiceophrenia”: a systematic overview of “Spice”‐related psychopathological issues and a case report Human Psychopharmacology: Clinical and Experimental July 1, 2013
- Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case–control study Psychological Medicine March 18, 2020
- Is “cannabis psychosis” a distinct category? European Psychiatry 1992
and 11 more in the library